Showing the single result

  • Rapact Everolimus Tablet PackRapact Everolimus Tablet Pack

    Rapact (Everolimus)

    0 out of 5
    Price range: $1,600 through $4,740

    Rapact (Everolimus Tablets) contains everolimus, an mTOR pathway inhibitor used to treat advanced renal cell carcinoma, hormone‑receptor–positive breast cancer (with exemestane), neuroendocrine tumors, and tuberous sclerosis complex‑related subependymal giant cell astrocytoma (SEGA) and renal angiomyolipoma. Taken orally under specialist supervision, Rapact reduces tumor growth and disease progression.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page

End of content

End of content